UHS stock hits 52-week low at 153.16 USD

Universal Health Services (NYSE:UHS) stock has reached a 52-week low, hitting a price of 153.16 USD. Trading at an attractive P/E ratio of 8.59x and showing strong revenue growth of 9.73%, InvestingPro analysis suggests the stock is currently undervalued. This marks a significant downturn for the company, which has seen its stock price decline by 27.64% over the past year. The healthcare services provider has faced various challenges, contributing to this downward trend in its stock performance. Investors are closely monitoring UHS as it navigates a challenging market environment, with the recent low reflecting broader pressures within the healthcare sector. InvestingPro data reveals the stock is in oversold territory, with 10+ additional exclusive insights available to subscribers, including detailed analysis of the company’s financial health and growth prospects.

In other recent news, Universal Health Services announced a dividend of $0.20 per share, set to be paid on September 16, 2025, to shareholders of record as of September 2, 2025. BofA Securities downgraded the company’s stock from Neutral to Underperform, citing concerns over Medicaid and Affordable Care Act exchange cuts following the recent Reconciliation Bill. Cantor Fitzgerald maintained its Neutral rating with a price target of $227.00, noting that patient volume trends may not yet be fully reflected in sell-side estimates. UBS reaffirmed its Buy rating and $280.00 price target, despite challenges in the behavioral health segment, and mentioned that acute care volumes are meeting expectations. Morgan Stanley (NYSE:MS) reiterated an Equalweight rating with a $200.00 price target after a discussion with the company’s CFO, highlighting solid utilization trends in the acute business and growth in the behavioral sector through price adjustments.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.